• Prinicipal Investigator(s): Hyunjoon Park
    Award Dates: July 1, 2014 - June 30, 2015
    Aim: RC28 Conference is a well-known venue for scholars from various parts of the world to meet and discuss theoretical and policy issues related to social inequality which is of growing concern in many countries. Having sessions particularly related to aging and life course in RC28 conference, we hope to stimulate public conversations on socioeconomic disparities in aging, life course trajectories, and inter-generational wealth transfers and savings from comparative and international perspectives. The conference will provide an important opportunity for scholars and public policymakers to discuss various experiences and challenges each country faces in relation to aging population.
  • Prinicipal Investigator(s): Jere R. Behrman
    Award Dates: September 15, 2014 - June 30, 2015
  • Prinicipal Investigator(s): Linda H. Aiken, Herbert L. Smith
    Award Dates: September 15, 2014 - June 30, 2015
    Aim: Good health care for the aging U.S. population is inextricably tied to the “health” of the also-aging nursing workforce. The willingness of nurses to continue working is tied to their job satisfaction, which includes benefits (retirement, health). More information linking the organizational aspects of nursing—including benefits and nurses’ knowledge about benefits—to nurse job satisfaction, burnout, and plans for retirement is crucial to national healthcare.
  • Prinicipal Investigator(s): Starc, Amanda
    Award Dates: July 1, 2014 - June 30, 2016
    Aim: In the United States, prescription drug spending is a large and growing component of both total health spending and overall GDP; understanding the determinants of drug spending is important from an economic perspective and as a matter of national policy. This project focuses particular attention on generic pharmaceutical pricing, and the extent to which two crucial inputs – manufacturer market structure and government intervention – determine the prices paid throughout the supply chain. In doing so, we hope to shed new light on the causal welfare effects of several policies regarding pharmaceutical competition and regulation.
  • Prinicipal Investigator(s): Chenoa Flippen
    Award Dates: September 15, 2014 - June 30, 2015